XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

XIAOPI Formula Inhibits Breast Cancer Stem Cells via Suppressing Tumor-Associated Macrophages/C-X-C Motif Chemokine Ligand 1 Pathway

Published:2019-11-15 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

Wang Shengqi,Liu Xiaoyan,Huang Renlun,Zheng Yifeng,Wang Neng,Yang Bowen,Situ Honglin,Lin Yi,Wang Zhiyu

Funder

National Natural Science Foundation of China

Guangdong Science and Technology Department

Science and Technology Planning Project of Guangdong Province

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference61 articles.

1. A CXCL1 paracrine network links cancer chemoresistance and metastasis;Acharyya;Cell,2012

2. Cancer scenario in India with future perspectives;Ali;Cancer Ther.,2011

3. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2);Allemani;Lancet,2015

4. Understanding the tumor immune microenvironment (TIME) for effective therapy;Binnewies;Nat. Med.,2018

5. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA. Cancer J. Clin.,2018

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SPDYC serves as a prognostic biomarker related to lipid metabolism and the immune microenvironment in breast cancer;Immunologic Research;2024-06-18

2. Fu-Zheng-Yi-Liu Formula inhibits the stem cells and metastasis of prostate cancer via tumor-associated macrophages/C-C motif chemokine ligand 5 pathway in tumor microenvironment;Chinese Journal of Natural Medicines;2024-06

3. Modulatory Effects of XIAOPI Formula on CXCL1 and Selected Outcomes in Triple-Negative Breast Cancer: A Randomized Controlled Clinical Trial;Breast Cancer: Targets and Therapy;2024-05

4. Targeting chemokine-receptor mediated molecular signaling by ethnopharmacological approaches;Journal of Ethnopharmacology;2024-05

5. Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling;Journal of Experimental & Clinical Cancer Research;2024-04-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3